Rowley Law PLLC Investigates iTeos Therapeutics Acquisition for Securities Law Violations

Rowley Law PLLC is investigating iTeos Therapeutics' proposed acquisition by Concentra Biosciences for potential securities law violations. Stockholders will receive $10.047 and one contingent value right per share. The transaction is expected to close in Q3 2025. Shareholders interested in additional information can visit rowleylawpllc.com/investigation/itos.

Rowley Law PLLC has launched an investigation into potential securities law violations by iTeos Therapeutics, Inc. (NASDAQ: ITOS) and its board of directors in relation to the proposed acquisition by Concentra Biosciences, LLC. The investigation centers on whether the acquisition process has complied with relevant securities laws.

According to the latest press release [1], the acquisition deal, expected to close in the third quarter of 2025, offers stockholders of iTeos Therapeutics $10.047 and one contingent value right per share. The contingent value right entitles shareholders to additional shares or cash in the future, depending on the performance of Concentra Biosciences.

Shareholders interested in obtaining more information about the investigation can visit Rowley Law PLLC's website at [http://www.rowleylawpllc.com/investigation/itos/](http://www.rowleylawpllc.com/investigation/itos/) or contact Shane Rowley, Esq., at 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC specializes in representing shareholders in class actions and derivative lawsuits in complex corporate litigation. The firm has been involved in numerous high-profile cases and has a strong track record of advocating for shareholder rights.

The investigation by Rowley Law PLLC underscores the importance of thorough due diligence and transparency in corporate acquisitions. It serves as a reminder to investors to stay vigilant and seek legal advice if they suspect any irregularities in corporate transactions.

References:
[1] https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-302509917.html
[2] https://www.marketscreener.com/news/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-ce7c5cdcda8ef722
[3] https://www.morningstar.com/news/pr-newswire/20250721ny34377/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc